<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9805560</article-id>
    <article-id pub-id-type="pmid">36342236</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btac721</article-id>
    <article-id pub-id-type="publisher-id">btac721</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Paper</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Data and Text Mining</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>ViMRT: a text-mining tool and search engine for automated virus mutation recognition</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Tong</surname>
          <given-names>Yuantao</given-names>
        </name>
        <aff><institution>Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, Shanghai 200092, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tan</surname>
          <given-names>Fanglin</given-names>
        </name>
        <aff><institution>Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, Shanghai 200092, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Huang</surname>
          <given-names>Honglian</given-names>
        </name>
        <aff><institution>Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, Shanghai 200092, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Zeyu</given-names>
        </name>
        <aff><institution>Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, Shanghai 200092, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zong</surname>
          <given-names>Hui</given-names>
        </name>
        <aff><institution>Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, Shanghai 200092, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xie</surname>
          <given-names>Yujia</given-names>
        </name>
        <aff><institution>Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, Shanghai 200092, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Huang</surname>
          <given-names>Danqi</given-names>
        </name>
        <aff><institution>Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, Shanghai 200092, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cheng</surname>
          <given-names>Shiyang</given-names>
        </name>
        <aff><institution>Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, Shanghai 200092, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wei</surname>
          <given-names>Ziyi</given-names>
        </name>
        <aff><institution>Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, Shanghai 200092, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Fang</surname>
          <given-names>Meng</given-names>
        </name>
        <aff><institution>Department of Laboratory Medicine, Shanghai Eastern Hepatobiliary Surgery Hospital</institution>, Shanghai 200438, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Crabbe</surname>
          <given-names>M James C</given-names>
        </name>
        <aff><institution>Wolfson College, Oxford University</institution>, Oxford OX2 6UD, <country country="GB">UK</country></aff>
        <aff><institution>Institute of Biomedical and Environmental Science &amp; Technology, University of Bedfordshire</institution>, Luton LU1 3JU, <country country="GB">UK</country></aff>
        <aff><institution>School of Life Sciences, Shanxi University</institution>, Taiyuan 030006, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Wang</surname>
          <given-names>Ying</given-names>
        </name>
        <aff><institution>Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, Shanghai 200092, <country country="CN">China</country></aff>
        <aff><institution>Department of Laboratory Medicine, Shanghai Eastern Hepatobiliary Surgery Hospital</institution>, Shanghai 200438, <country country="CN">China</country></aff>
        <xref rid="btac721-cor1" ref-type="corresp"/>
        <!--nadger_wang@139.com-->
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1562-0045</contrib-id>
        <name>
          <surname>Zhang</surname>
          <given-names>Xiaoyan</given-names>
        </name>
        <aff><institution>Research Center for Translational Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University</institution>, Shanghai 200092, <country country="CN">China</country></aff>
        <xref rid="btac721-cor1" ref-type="corresp"/>
        <!--xyzhang@tongji.edu.cn-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Wren</surname>
          <given-names>Jonathan</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btac721-cor1">To whom correspondence should be addressed. Email: <email>xyzhang@tongji.edu.cn</email> or <email>nadger_wang@139.com</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>1</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-11-07">
      <day>07</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>07</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <volume>39</volume>
    <issue>1</issue>
    <elocation-id>btac721</elocation-id>
    <history>
      <date date-type="received">
        <day>13</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>24</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="editorial-decision">
        <day>31</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>04</day>
        <month>11</month>
        <year>2022</year>
      </date>
      <date date-type="corrected-typeset">
        <day>15</day>
        <month>11</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s) 2022. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btac721.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>Virus mutation is one of the most important research issues which plays a critical role in disease progression and has prompted substantial scientific publications. Mutation extraction from published literature has become an increasingly important task, benefiting many downstream applications such as vaccine design and drug usage. However, most existing approaches have low performances in extracting virus mutation due to both lack of precise virus mutation information and their development based on human gene mutations.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>We developed ViMRT, a text-mining tool and search engine for automated virus mutation recognition using natural language processing. ViMRT mainly developed 8 optimized rules and 12 regular expressions based on a development dataset comprising 830 papers of 5 human severe disease-related viruses. It achieved higher performance than other tools in a test dataset (1662 papers, 99.17% in F1-score) and has been applied well to two other viruses, influenza virus and severe acute respiratory syndrome coronavirus-2 (212 papers, 96.99% in F1-score). These results indicate that ViMRT is a high-performance method for the extraction of virus mutation from the biomedical literature. Besides, we present a search engine for researchers to quickly find and accurately search virus mutation-related information including virus genes and related diseases.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>ViMRT software is freely available at <ext-link xlink:href="http://bmtongji.cn:1225/mutation/index" ext-link-type="uri">http://bmtongji.cn:1225/mutation/index</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>81972914</award-id>
        <award-id>81573023</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Fundamental Research Funds for the Central Universities</institution>
            <institution-id institution-id-type="DOI">10.13039/501100012226</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>22120200014</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Shanghai âRising Stars of Medical Talentâ Youth Development Program</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2019-72</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="7"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Viruses cause many human diseases including cancers by persistent chronic infection and induce public health insecurity (<xref rid="btac721-B12" ref-type="bibr">Escandon <italic toggle="yes">et al.</italic>, 2021</xref>; <xref rid="btac721-B27" ref-type="bibr">Zapatka <italic toggle="yes">et al.</italic>, 2020</xref>). Viral mutation is the ultimate source of viral genetic diversity and evolution which plays a key role in the relationship between the virus and disease progression (<xref rid="btac721-B20" ref-type="bibr">Sanjuan and Domingo-Calap, 2016</xref>). For example, the point mutations of hepatitis B virus (HBV) surface are closely related to immune and vaccine escape, resulting in active viral replication and the development of hepatocellular carcinoma (<xref rid="btac721-B29" ref-type="bibr">Zhao <italic toggle="yes">et al.</italic>, 2021</xref>). Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants can cause a very high risk of infection (<xref rid="btac721-B2" ref-type="bibr">Araf <italic toggle="yes">et al.</italic>, 2022</xref>). Substantial virus research has been prompted by the importance of virus mutation across many diverse clinical and basic research fields and reported in PubMed with constant updates, which provides an invaluable resource for obtaining key information about virus genomic variants. Therefore, it is of great significance for clinical diagnosis and treatment to perform extraction and relationship analysis of virus-related mutations, genes and disease entities by the efficient use of the rich literature.</p>
    <p>However, those unstructured texts are limited by the insufficient feasibility of traditional manual curation in utilization, as it cannot be carried out on all of the available literature. Furthermore, due to the inconsistency of virus mutations and the lack of standard mutation nomenclature, the conventional âKeyword Searchâ may be difficult to quickly and non-redundantly get desired mutation information from literature in PubMed. As such, extracting, mining and integrating virus mutation-related information from those extremely large amounts of literature has become an increasingly important task in many downstream applications, such as virus mutation database development (<xref rid="btac721-B8" ref-type="bibr">Davey <italic toggle="yes">et al.</italic>, 2014</xref>; <xref rid="btac721-B22" ref-type="bibr">Wang <italic toggle="yes">et al.</italic>, 2022</xref>), immune escape mechanism exploration (<xref rid="btac721-B14" ref-type="bibr">Huang <italic toggle="yes">et al.</italic>, 2020</xref>), vaccine design and updating (<xref rid="btac721-B25" ref-type="bibr">Xie <italic toggle="yes">et al.</italic>, 2021</xref>), drug resistance mutation analysis and assistance in clinical personalized medicine (<xref rid="btac721-B6" ref-type="bibr">Chen <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btac721-B26" ref-type="bibr">Yeo <italic toggle="yes">et al.</italic>, 2020</xref>).</p>
    <p>With the wide application of text mining and natural language processing in the biomedical field, many named-entity recognition and named-entity normalization tools for mutation have been successively developed to overcome the problem of mutation recognition from the biomedical literature (<xref rid="btac721-B16" ref-type="bibr">Lee <italic toggle="yes">et al.</italic>, 2021</xref>). For example, MutationFinder uses about 700 regular expressions to identify individual nucleotide or amino acid point mutations or the mutations in simple natural language forms (<xref rid="btac721-B4" ref-type="bibr">Caporaso <italic toggle="yes">et al.</italic>, 2007</xref>). Extractor of mutation can identify insertions or deletion mutations in addition to point mutations based on regular expression (<xref rid="btac721-B11" ref-type="bibr">Doughty <italic toggle="yes">et al.</italic>, 2011</xref>). tmVar comprehensively uses conditional random fields (CRF) with regular expression for mutation recognitions (<xref rid="btac721-B24" ref-type="bibr">Wei <italic toggle="yes">et al.</italic>, 2013</xref>). AVADA is another machine learning and regular expression-based mutation extraction tool which improved gene-mutation mapping in full-text papers (<xref rid="btac721-B3" ref-type="bibr">Birgmeier <italic toggle="yes">et al.</italic>, 2020</xref>). nala mines natural language processing mutations from the literature (<xref rid="btac721-B5" ref-type="bibr">Cejuela <italic toggle="yes">et al.</italic>, 2017</xref>). However, those tools aimed at identifying human gene mutation. The accuracy and recall largely reduce when they are applied to identify virus mutation due to the specific written forms of virus mutation significantly differing from human mutation. For example, most written forms often contain slash symbols resulting from occurring multiple mutations at a single site, e.g. E138A/G/K/Q/R/S in human immunodeficiency virus (HIV) reverse transcriptase region (<xref rid="btac721-B18" ref-type="bibr">Martin-Alonso <italic toggle="yes">et al.</italic>, 2020</xref>). The other popular form of virus variant nomenclature includes the lowercase virus gene at the beginning, e.g. sG145R in the HBV S gene (<xref rid="btac721-B7" ref-type="bibr">Chen <italic toggle="yes">et al.</italic>, 2020</xref>). Consequently, developing a tool for virus mutation from free text is promising but remains a challenge especially for a variety of writing styles and the shortage of a unified nomenclature as shown by the human genome variation society (HGVS) (<xref rid="btac721-B9" ref-type="bibr">den Dunnen <italic toggle="yes">et al.</italic>, 2016</xref>). Moreover, extracting the relationship of virus mutation-related entities is also of great biological and clinical application in virus research, especially in genes and diseases (<xref rid="btac721-B2" ref-type="bibr">Araf <italic toggle="yes">et al.</italic>, 2022</xref>; <xref rid="btac721-B21" ref-type="bibr">Soulie <italic toggle="yes">et al.</italic>, 2020</xref>). There are several semantic search engines for linking genomic variant data, such as LitVar (<xref rid="btac721-B1" ref-type="bibr">Allot <italic toggle="yes">et al.</italic>, 2018</xref>), PubTator (<xref rid="btac721-B23" ref-type="bibr">Wei <italic toggle="yes">et al.</italic>, 2019</xref>), but their information focuses on human mutations or keyword-based search, which hinders quality improvement (sensitivity and specificity) of search results.</p>
    <p>To address the above difficulties and challenges, this study developed a novel localization recognition tool of virus mutation to extract and standardize mutation data from available literature, and further integrated the co-occurrence information of virus mutation between viral gene and human disease, with an attempt to design a user-friendly search engine to serve the requirement of researchers to quickly search and download mutation related information, thereby aiding experimental design and clinical guidelines.</p>
  </sec>
  <sec>
    <title>2 System and methods</title>
    <p>An overview of ViMRT is summarized in <xref rid="btac721-F1" ref-type="fig">FigureÂ 1</xref>, including virus dataset preparation, mutation recognition tool development, performance evaluation and web construction.</p>
    <fig position="float" id="btac721-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>A schematic overview of the ViMRT project. There are four major parts: dataset preparation (development dataset and test dataset construction), virus mutation recognition tool development (rule-based optimization and developed regular expression), evaluation and comparison (conventional method and additional dataset) and web construction (virus gene recognition, disease recognition and web interface design)</p>
      </caption>
      <graphic xlink:href="btac721f1" position="float"/>
    </fig>
    <sec>
      <title>2.1 Virus dataset preparation</title>
      <p>The gold standard file of virus mutation was collected from our previously developed ViMIC database (<xref rid="btac721-B22" ref-type="bibr">Wang <italic toggle="yes">et al.</italic>, 2022</xref>), consisting of mutation-related literature in five viruses, HBV, HIV, human papillomavirus (HPV), human T-cell lymphotropic virus type-1 (HTLV1) and Epstein-Barr virus. In this study, the positive samples consisted of 1246 abstracts containing virus mutation information. To balance the positive and negative samples, 1246 abstracts with no virus mutation information were selected as the negative samples. All collected virus literature was divided into a development dataset and a test dataset on a scale of 1:2. In total, 415 positive abstracts and 415 negative abstracts were used as the development dataset, and 831 positive abstracts and 831 negative abstracts were used as the independent test dataset. All virus datasets are available at: <ext-link xlink:href="http://bmtongji.cn:1225/mutation/dataset" ext-link-type="uri">http://bmtongji.cn:1225/mutation/dataset</ext-link>.</p>
    </sec>
    <sec>
      <title>2.2 Mutation recognition tool development</title>
      <p>ViMRT has two independent modules to identify mutations as follows:</p>
      <sec>
        <title>2.2.1âModule 1: Optimizing the recognition result of tmVar by rule patterns</title>
        <p>In this module, we first used the tmVar (<xref rid="btac721-B24" ref-type="bibr">Wei <italic toggle="yes">et al.</italic>, 2013</xref>) to obtain mutation information and then we built eight rule patterns to correct and standardize mutation identification of tmVar based on the site of mutation in the original sentences and mutation displacement (<xref rid="btac721-T1" ref-type="table">TableÂ 1</xref>). This mainly included two aspects: negative results (identified entities are not actual virus mutations) and positive results (identified entities are actual virus mutations). For negative results, our rules mainly dealt with three recognition errors: multiple mutations linked with a slash (âA1762T/G1764Aâ was identified as âA1762T/Gâ by tmVar), non-sense mutation (âQ118R/Stopâ was identified as âQ118R/Sâ by tmVar) and the three-letter abbreviation of amino acid (âPro130Ile/Thr/Serâ was identified as âPro130Ile/Tâ by tmVar). The mentioned errors resulted from incomplete extractions of words. Thus, the recognition result can be optimized by completing words in sentences, and the incorrect recognition part was excluded after optimization. For example, âA1762T/Gâ by tmVar will be extended into âA1762T/G1764Aâ and normalized as âA1762Tâ and âG1764Aâ, without the negative result âA1762Gâ. For positive results, our rules mainly standardized five written forms: mutation with lowercase viral gene (rtM204V), simple natural language written form with a linking preposition (a mutation from T to G at nucleotide 178), mutation written form with â&gt;â (8403A&gt;G), a word beginning with mutation level (p.Lys316Glu) and a special written form of HPV mutant (E-C109G).</p>
        <table-wrap position="float" id="btac721-T1">
          <label>Table 1.</label>
          <caption>
            <p>The optimization rules of virus mutation recognized by tmVar</p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col valign="top" align="left" span="1"/>
              <col valign="top" align="left" span="1"/>
              <col valign="top" align="left" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th rowspan="1" colspan="1">Result type</th>
                <th rowspan="1" colspan="1">Rule patterns</th>
                <th rowspan="1" colspan="1">Examples</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="3" colspan="1">False positive</td>
                <td rowspan="1" colspan="1">Include â\d{1,}\D{1,}\d{1,}|[/,]â &amp; no lowercase letters and not end with an âSâ</td>
                <td rowspan="1" colspan="1">A1762T/G1764T (A1762T/G<xref rid="tblfn1" ref-type="table-fn"><sup>a</sup></xref>)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">End with an âSâ &amp; include âSTOP|stop|Stop|Stâ</td>
                <td rowspan="1" colspan="1">Q118R/Stop (Q118R/S<xref rid="tblfn1" ref-type="table-fn"><sup>a</sup></xref>)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Include the three characters of 20 amino acids</td>
                <td rowspan="1" colspan="1">Pro130Ile/Thr/Ser (Pro130Ile/T<xref rid="tblfn1" ref-type="table-fn"><sup>a</sup></xref>)</td>
              </tr>
              <tr>
                <td rowspan="5" colspan="1">True positive</td>
                <td rowspan="1" colspan="1">Include abbreviation of virus gene</td>
                <td rowspan="1" colspan="1">rtM204V (M204V<xref rid="tblfn2" ref-type="table-fn"><sup>b</sup></xref>)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Natural language include âto|with|by|[-]|for|ins|del|Non|Delta|of|atâ</td>
                <td rowspan="1" colspan="1">A mutation from T to G at nucleotide 178 (T178G<xref rid="tblfn2" ref-type="table-fn"><sup>b</sup></xref>)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Include â&gt;â and not include lowercase âl|u|s|p|r|y|h|i|n|e|o|m|vâ</td>
                <td rowspan="1" colspan="1">8403A&gt;G (A8403G<xref rid="tblfn2" ref-type="table-fn"><sup>b</sup></xref>)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Begin with mutation levels (c.|g.|p.)</td>
                <td rowspan="1" colspan="1">p.Lys316Glu (K316E<xref rid="tblfn2" ref-type="table-fn"><sup>b</sup></xref>)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Special written form of HPV mutant and include âA|C|E|G|Tâ</td>
                <td rowspan="1" colspan="1">E-C109G (C109G<xref rid="tblfn2" ref-type="table-fn"><sup>b</sup></xref>)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tblfn1">
              <label>a</label>
              <p>The identification errors. For example, A1762T/G1764T are identified A1762T/G; This will be mistaken for A1762T and A1762G in the final identification results.</p>
            </fn>
            <fn id="tblfn2">
              <label>b</label>
              <p>The normalized mutation written forms.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>2.2.2 Module 2: Developing regular expression patterns to recognize virus mutation</title>
        <p>Based on the development dataset and false positive results of tmVar, we classified the written form of virus mutation into three signatures for nucleotide and amino acid mutation: standard mutation (SM: written form of mutation with no punctuation), semi-standard mutation (SSM: written form of mutation containing punctuation) and natural language mutation (NLM: written form of mutation with the natural language) and then constructed corresponding regular expression patterns (<xref rid="btac721-T2" ref-type="table">TableÂ 2</xref>). Finally, we combined the united results of the above two modules as the final recognition result of ViMRT with a standardized written format which consisted of the wild type with uppercase letter, the location number of the mutation and the mutated type with uppercase letter.</p>
        <table-wrap position="float" id="btac721-T2">
          <label>Table 2.</label>
          <caption>
            <p>Regular expression patterns of virus mutation based on development dataset</p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col valign="top" align="left" span="1"/>
              <col valign="top" align="left" span="1"/>
              <col valign="top" align="left" span="1"/>
              <col valign="top" align="left" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th rowspan="1" colspan="1">Type</th>
                <th rowspan="1" colspan="1">Signatures</th>
                <th rowspan="1" colspan="1">Regular expression patterns</th>
                <th rowspan="1" colspan="1">Examples</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="8" colspan="1">Amino acid</td>
                <td rowspan="3" colspan="1">SM</td>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>[AC-IK-NP-TV-Y](/[AC-IK-NP-TV-Y]){0,}([1-9]\d{0,3})((STOP|stop|Stop|St\.|\*|[AC-IK-NP-TV-Y]))(/(STOP|stop|Stop|St\.|\*|[AC-IK-NP-TV-Y])){0,}</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">M204I</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>[AC-IK-NP-TV-Y][1-9]\d{1,3} ?(STOP|Stop|stop|St\.|\*)</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">W196stop</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>([AC-IK-NP-TV-Y]|[ACGHILMPSTV][aehilrsy][aeglnoprstuy])(-?[1-9]\d{1,3}-?)([ACGHILMPSTV][aehilrsy][aeglnoprstuy]|Stop)(?![-\d])</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">C144Lys</td>
              </tr>
              <tr>
                <td rowspan="3" colspan="1">SSM</td>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>[ACGHILMPSTV][aehilrsy][aeglnoprstuy](/[ACGHILMPSTV][aehilrsy][aeglnoprstuy]){1,}(-?[1-9]\d{1,3}-?)([ACGHILMPSTV][aehilrsy][aeglnoprstuy]|Stop)(/[ACGHILMPSTV][aehilrsy][aeglnoprstuy]|Stop){1,}</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">Met204Ile/Val</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>([1-9]\d{1,3}-?[AC-IK-NP-TV-Y]|[AC-IK-NP-TV-Y][1-9]\d{1,3})--(&amp;gt;|&gt;)[AC-IK-NP-TV-Y]')</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">555-V--&gt;I</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>(A(la|rg)|As[np]|Cys|Gl[nuy]|His|Ile|L(eu|ys)|Met|P(he|ro)|Ser|T[hy]r|Trp|Val)-[1-9]\\d{1,3}--(&amp;gt;|&gt;) (A(la|rg)|As[np]|Cys|Gl[nuy]|His|Ile|L(eu|ys)|Met|P(he|ro)|Ser|T[hy]r|Trp|Val)</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">Val-555--&gt;Ile</td>
              </tr>
              <tr>
                <td rowspan="2" colspan="1">NLM</td>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>([ACGHILMPSTV][aehilrsy][aeglnoprstuy])(\(?)([1-9]\\d{1,3})(\))([-]to[-]|--(&amp;gt;|&gt;))([ACGHILMPSTV][aehilrsy][aeglnoprstuy])</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">Leu (526)-to-Met</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>([ACGHILMPSTV][aehilrsy][aeglnoprstuy])(?P&lt;site&gt;[1-9]\d{1,3})([-]to[-]|--(&amp;gt;|&gt;))([ACGHILMPSTV][aehilrsy][aeglnoprstuy])(?P=site)</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">Val184-to-Ala184</td>
              </tr>
              <tr>
                <td rowspan="4" colspan="1">Nucleotide</td>
                <td rowspan="1" colspan="1">SM</td>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>[ACGT](/[ACGT]){0,}([1-9]\d{2,4})[ACGT](/[ACGT]){0,}</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">G1613A</td>
              </tr>
              <tr>
                <td rowspan="2" colspan="1">SSM</td>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>[1-9]\d{2,4}[a-z\( ]*?[ACGT]--(&amp;gt;|&gt;)[ACGT][\)]?</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">1762 (A--&gt;T)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>[1-9]\d{2,4} \([ACGT]\-[ACGT]\)</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">1896 (G-A)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">NLM</td>
                <td rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>[ACGT][-]to[-][ACGT] .*?at .*?nt.*?[1-9]\d{2,4}</p>
                    </list-item>
                  </list>
                </td>
                <td rowspan="1" colspan="1">G-to-A mutation at nucleotide (nt) 1896</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tblfn3">
              <p><italic toggle="yes">Note</italic>: Classification of mutation signatures as found in the literature.</p>
            </fn>
            <fn id="tblfn4">
              <p>SM, standard mutation; SSM, semi-standard mutation; NLM, natural language mutation.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
    </sec>
    <sec>
      <title>2.3 Performance evaluation</title>
      <p>To evaluate the performance of ViMRT, we compared ViMRT with three other classic tools (tmVar, MutationFinder and nala). Moreover, we used the additional dataset including the abstracts of influenza virus (IV) and SARS-CoV-2 to further evaluate the recognition effect in other viruses. We calculated three different parameters: Precision, Recall and F1-score. The three parameters were defined as follows:
<disp-formula id="E1"><label>(1)</label><mml:math id="M1" display="block" overflow="scroll"><mml:mi mathvariant="normal">Precision</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">Â </mml:mi><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">TP</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">TP</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">FP</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mo>Â </mml:mo></mml:math></disp-formula><disp-formula id="E2"><label>(2)</label><mml:math id="M2" display="block" overflow="scroll"><mml:mi mathvariant="normal">Recall</mml:mi><mml:mi mathvariant="normal">Â </mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">Â </mml:mi><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">TP</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">TP</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">FN</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mi mathvariant="normal">Â </mml:mi></mml:math></disp-formula><disp-formula id="E3"><label>(3)</label><mml:math id="M3" display="block" overflow="scroll"><mml:mi mathvariant="normal">F</mml:mi><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi mathvariant="normal">score</mml:mi><mml:mi mathvariant="normal">Â </mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">Â </mml:mi><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi mathvariant="normal">*</mml:mi><mml:mi mathvariant="normal">Precision</mml:mi><mml:mi mathvariant="normal">*</mml:mi><mml:mi mathvariant="normal">Recall</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">Precision</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">Recall</mml:mi></mml:mrow></mml:mfrac><mml:mo>Â </mml:mo><mml:mo>,</mml:mo></mml:math></disp-formula></p>
      <p>where TP, FP and FN represent the numbers of true positive (identified entities are actual virus mutation), false positive (identified entities are not actual virus mutation) and false negative (identified non-virus mutation entities are actual virus mutation), respectively.</p>
    </sec>
    <sec>
      <title>2.4 Web construction</title>
      <sec>
        <title>2.4.1âVirus genes extraction</title>
        <p>We first built the virus gene corpus from PubMed and the NCBI gene database (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/gene/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/gene/</ext-link>) due to the particularity of different viral genes and then developed Python scripts to identify the virus genes from the sentences including virus mutation.</p>
      </sec>
      <sec>
        <title>2.4.2âVirus mutation related diseases annotation</title>
        <p>We used the Stanza natural language processing (NLP) library (<ext-link xlink:href="https://github.com/stanfordnlp/stanza" ext-link-type="uri">https://github.com/stanfordnlp/stanza</ext-link>) for many human languages to identify the diseases from the sentences including virus mutation and further developed Python scripts to extract related-disease information based on disease corpus collected from CTD (<ext-link xlink:href="http://ctdbase.org" ext-link-type="uri">http://ctdbase.org</ext-link>).</p>
      </sec>
      <sec>
        <title>2.4.3âWeb search engine development</title>
        <p>To quickly search and find the interactions of virus mutation and related information for researchers, we used ViMRT to identify virus mutations, genes and diseases from the 9629 PubMed abstracts and 3160 PMC full-text articles and calculated the co-occurrence correlation of the variant and disease in sentences by the Fisher's test. We finally constructed the user-friendly web pages for visual search and display using Django 3.2.6.</p>
      </sec>
    </sec>
  </sec>
  <sec>
    <title>3 Results</title>
    <sec>
      <title>3.1 Virus mutation dataset</title>
      <p>Viral mutation gold data contained 1246 abstracts on five viruses (2349 mutations) from the ViMIC database. The development dataset and test dataset were allocated in a ratio of 1:2. In total, SM accounted for 62.60% of total annotations. SSM was 36.45% and the fraction of NLM was only 0.95% (<xref rid="btac721-F2" ref-type="fig">Fig.Â 2A</xref>). The fraction of mutation signatures in the corpus of different viruses is shown in <xref rid="btac721-F2" ref-type="fig">FigureÂ 2B</xref>.</p>
      <fig position="float" id="btac721-F2">
        <label>Fig. 2.</label>
        <caption>
          <p>The percentage of different mutation signatures in our corpus and comparison of recognition results. (<bold>A</bold>) The percentage of different mutation signatures in the total corpus (1246 abstracts). (<bold>B</bold>) The percentage of different mutation signatures in the corpus of different viruses. (<bold>C</bold>) The percentage of different mutation signatures in SARS-CoV-2 and IV corpus (212 abstracts). (<bold>D</bold>) The percentage of false negative and true positive mutation signatures in the test dataset by ViMRT, MutationFinder, nala and tmVar, respectively</p>
        </caption>
        <graphic xlink:href="btac721f2" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>3.2 Evaluation and comparison with existing tools on different datasets</title>
      <p>To evaluate the performance of ViMRT, we compared recognition results with three other conventional tools, tmVar, nala and MutationFinder in the test dataset. Notably, <xref rid="btac721-T3" ref-type="table">TableÂ 3</xref> shows that ViMRT outperformed three other methods with the best two evaluation metrics (Recall: 98.95%, F1-score: 99.17%) and the precision also reached 99.39%. ViMRT displays the state-of-art performance to recognize the mutation of five viruses from the literature used in this study. To further estimate the application of our model in other viral contexts, we manually annotated 212 mutation-related abstracts of SARS-CoV-2 and IV. <xref rid="btac721-F2" ref-type="fig">FigureÂ 2C</xref> shows the fraction of mutation signatures. The recognition results are presented in <xref rid="btac721-T4" ref-type="table">TableÂ 4</xref>. The performance of our method was higher than that of the three other methods, which also shows the feasibility and effectiveness of our method.</p>
      <table-wrap position="float" id="btac721-T3">
        <label>Table 3.</label>
        <caption>
          <p>Performance evaluation of mutation recognition using different tools on test dataset</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Tool</th>
              <th rowspan="1" colspan="1">Precision (%)</th>
              <th rowspan="1" colspan="1">Recall (%)</th>
              <th rowspan="1" colspan="1">F1-score (%)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">ViMRT</td>
              <td rowspan="1" colspan="1">99.39</td>
              <td rowspan="1" colspan="1">
                <bold>98.95</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>99.17</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">tmVar</td>
              <td rowspan="1" colspan="1">91.50</td>
              <td rowspan="1" colspan="1">69.10</td>
              <td rowspan="1" colspan="1">78.74</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Nala</td>
              <td rowspan="1" colspan="1">93.81</td>
              <td rowspan="1" colspan="1">68.80</td>
              <td rowspan="1" colspan="1">79.38</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MutationFinder</td>
              <td rowspan="1" colspan="1">
                <bold>99.81</bold>
              </td>
              <td rowspan="1" colspan="1">59.26</td>
              <td rowspan="1" colspan="1">74.37</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tblfn55">
            <p>The bold values indicate the best value per metric.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap position="float" id="btac721-T4">
        <label>Table 4.</label>
        <caption>
          <p>Performance evaluation of mutation recognition using different tools on SARS-CoV-2 and IV dataset</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Tools</th>
              <th rowspan="1" colspan="1">Precision (%)</th>
              <th rowspan="1" colspan="1">Recall (%)</th>
              <th rowspan="1" colspan="1">F1-score (%)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">ViMRT</td>
              <td rowspan="1" colspan="1">99.11</td>
              <td rowspan="1" colspan="1">
                <bold>94.95</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>96.99</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">tmVar</td>
              <td rowspan="1" colspan="1">96.96</td>
              <td rowspan="1" colspan="1">92.72</td>
              <td rowspan="1" colspan="1">94.79</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">nala</td>
              <td rowspan="1" colspan="1">97.15</td>
              <td rowspan="1" colspan="1">84.59</td>
              <td rowspan="1" colspan="1">90.44</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MutationFinder</td>
              <td rowspan="1" colspan="1">
                <bold>100</bold>
              </td>
              <td rowspan="1" colspan="1">78.25</td>
              <td rowspan="1" colspan="1">87.80</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tblfn55a">
            <p>The bold values indicate the best value per metric.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec>
      <title>3.3 Recognition comparison with existing tools on SM, SSM and NLM</title>
      <p>We further compared the recognition results of four methods in three mutation signatures (<xref rid="btac721-T5" ref-type="table">TableÂ 5</xref>). For SM, four methods could perform well in mutations that resembled the HGVS nomenclature. However, ViMRT and tmVar could identify the gene mixed-written form and nonsense mutations that were not identified by nala or MutationFinder. For SSM, ViMRT, tmVar and nala could identify a large proportion of written forms, but only ViMRT could correctly detect SSM which contains more than two slashes. For NLM, ViMRT, tmVar and nala could discern the mutations in simple written form of natural language. <xref rid="btac721-F2" ref-type="fig">FigureÂ 2D</xref> shows the percentage of different mutation signatures with true positive results and false negative results by ViMRT, MutationFinder, nala and tmVar. ViMRT performed more accurately than the three other tools, which had the highest percentage of positive results and the lowest percentage of negative results.</p>
      <table-wrap position="float" id="btac721-T5">
        <label>Table 5.</label>
        <caption>
          <p>Comparison of different tools on the recognition ability of SM, SSM and NLM</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Signatures</th>
              <th rowspan="1" colspan="1">Examples</th>
              <th rowspan="1" colspan="1">ViMRT</th>
              <th rowspan="1" colspan="1">tmVar</th>
              <th rowspan="1" colspan="1">nala</th>
              <th rowspan="1" colspan="1">Mutation-Finder</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">SM</italic>
              </td>
              <td rowspan="1" colspan="1">M204I; Asp8Asn</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">rtI233V</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes<xref rid="tblfn5" ref-type="table-fn">â</xref></td>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">Y225del; 7434CIns</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">W182 stop; C69<xref rid="tblfn5" ref-type="table-fn">â</xref></td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes<xref rid="tblfn5" ref-type="table-fn">â</xref></td>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">SSM</italic>
              </td>
              <td rowspan="1" colspan="1">145G&gt;T; C2288A/T</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes<xref rid="tblfn5" ref-type="table-fn">â</xref></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">L180M+M204V</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">Y143R/C/D/G; A12S/P33S/P46S</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes<xref rid="tblfn5" ref-type="table-fn">â</xref></td>
              <td rowspan="1" colspan="1">Yes<xref rid="tblfn5" ref-type="table-fn">â</xref></td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">NLM</italic>
              </td>
              <td rowspan="1" colspan="1">Asn116-to-Thr116</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes<xref rid="tblfn5" ref-type="table-fn">â</xref></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">Alanine 206 had been replaced by a serine</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">G-A transition at position 5503</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">Yes<xref rid="tblfn5" ref-type="table-fn">â</xref></td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tblfn5">
            <p>âThe methods can incompletely recognize the examples listed.</p>
          </fn>
          <fn id="tblfn6">
            <p>SM, standard mutation; SSM, semi-standard mutation; NLM, natural language mutation.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec>
      <title>3.4 The ViMRT web search engine</title>
      <p>We developed the ViMRT web search engine by identifying mutations in 9629 abstracts and 3160 full texts and covered the annotations of viral genes and related diseases. It can be accessed through an easy-to-use graphical web interface, as shown in <xref rid="btac721-F3" ref-type="fig">FigureÂ 3</xref>. The web provides two ways to get variant information. One is a simple search. After users enter a query entity in the select bar on the home page, including virus mutation, gene or disease (<xref rid="btac721-F3" ref-type="fig">Fig.Â 3a</xref>), the web will return the best match entity results in its database (<xref rid="btac721-F3" ref-type="fig">Fig.Â 3b</xref>), which includes a list of publications containing highlighted entities, sorted by publication date. Another is co-occurrence correlation rank to search if the aim of users is not very clear. Users can firstly click âTo search the relationshipâ button on the home page, which will return co-occurrence correlation of mutation and disease including seven viruses by the histogram chart and table, and click âViewâ to get detailed information (<xref rid="btac721-F3" ref-type="fig">Fig.Â 3c</xref>). Those processes have three main features:</p>
      <fig position="float" id="btac721-F3">
        <label>Fig. 3.</label>
        <caption>
          <p>The ViMRT user interface and the usage guidance locally. Multiple clearly delimited zones allow users to perform search and visualize results, which include: (a) A query entity can be inputted on the home page, such as a virus mutation, virus gene or related disease. (b) The match query includes the detailed information of virus mutations, virus genes, and related diseases, sorted by the publication year in a descending order. (c) The co-occurrence correlation of viral mutation and related disease. The table shows co-occurrence score of mutation which have co-occurred in the same sentence with one disease by Fisher's test in each virus (***<italic toggle="yes">P</italic>â&lt;â0.001; **<italic toggle="yes">P</italic>â&lt;â0.01; *<italic toggle="yes">P</italic>â&lt;â0.05; ns, not significant). The histogram chart shows the co-occurrence correlation score of mutation and disease ranking top 10. (d) The user can select the entities menu to get sentence co-occurrence of different entities. (e) Users can also filter publications based on âYearâ, âPositionâ and âPMIDâ of publication matching the query. (f) Users can download mutation data on the âDatasetâ page and view the usage of ViMRT in the âDocsâ page with a detailed script</p>
        </caption>
        <graphic xlink:href="btac721f3" position="float"/>
      </fig>
      <p>First, for each result, it returns the searched entity with a red background as well as other entities with different colors including diseases, genes and other mutations (<xref rid="btac721-F3" ref-type="fig">Fig.Â 3b</xref>), which can very efficiently catch the entity information and research work. Second, users can filter the other co-occurrence entities by the table and the filter box at the left (<xref rid="btac721-F3" ref-type="fig">Fig.Â 3c and d</xref>) which are useful to find potential relations (e.g. C1653T mutation of HBV HBx/core promoter region is strongly associated with an increased risk of hepatocellular carcinoma and reported in many literatures). Third, users can also filter literature information through âYearâ, âPositionâ and âPMIDâ of publication (<xref rid="btac721-F3" ref-type="fig">Fig.Â 3e</xref>). The âDatasetâ page and âDocsâ page of the web provide the download to easily get complete mutation information of seven viruses and the local usage of ViMRT with a detailed script, respectively (<xref rid="btac721-F3" ref-type="fig">Fig.Â 3f</xref>).</p>
    </sec>
    <sec>
      <title>3.5 The localization usage of ViMRT</title>
      <p>The usage of ViMRT can realize three recognitions: virus mutation recognition, virus gene recognition and disease recognition. Firstly, virus mutation recognition includes downloading literature, optimizing the recognition results of tmVar by rule patterns and recognizing virus mutation by regular expression patterns. Secondly, the virus gene is identified by virus gene vocabulary and a gene match program. Thirdly, disease recognition is based on Stanza 1.4.0 and a normalizing script written by Python (v3.8.5). Full usage of ViMRT is minutely displayed on the âDocsâ page: <ext-link xlink:href="http://bmtongji.cn:1225/mutation/Docs" ext-link-type="uri">http://bmtongji.cn:1225/mutation/Docs</ext-link>.</p>
    </sec>
  </sec>
  <sec>
    <title>4 Discussion</title>
    <p>This study is the first to gather abundant virus mutation information and develop ViMRT to identify virus mutation by precise rules and regular expressions. It has achieved a higher performance for virus mutation recognition than other conventional tools. At the same time, we are the first to develop a search engine web about a variety of viruses for researchers to quickly search mutation-specific information that includes virus gene and related diseases as reported in the biomedical literatures.</p>
    <p>ViMRT displays some notable advantages in identifying virus mutation recognition. Firstly, ViMRT curated and created virus mutation information from five viruses closely related to human disease from the literature to comprehensively cover the majority of written forms. Next, based on that information, we designed rule patterns to optimize recognition results of tmVar, and further summarized three mutation signatures termed SM, SSM, NLM which characterized the written form preference of virus mutation in different literatures. Then we developed regular expressions to recognize mutations for each mutation signatures (<xref rid="btac721-T2" ref-type="table">TableÂ 2</xref>). As we have observed, ViMRT showed state-of-art performance compared to three other conventional tools (<xref rid="btac721-T3" ref-type="table">TableÂ 3</xref>), especially for the written form of virus mutation containing punctuation or gene. We also developed a specific search engine for seven viruses to realize mutation information visualization and mined the buried co-occurrence relationships with related diseases in the original paper, which can contribute to more quickly and accurately retrieving evidence aiding both basic research and clinical application compared to LitVar and Pubtator.</p>
    <p>In addition, we observed that ViMRT showed a slightly decreased but still good performance (all indicators &gt; 0.9) to recognize the mutation of SARS-CoV-2 and IV compared to five viruses (<xref rid="btac721-T4" ref-type="table">TableÂ 4</xref>), while the performance of three other tools on the corpus of SARS-CoV-2 and IV were better than those in the test dataset. The possible interpretation is that a lower proportion of SSM in SARS-CoV-2 and IV corpus caused the rise of recall of three other tools (<xref rid="btac721-F2" ref-type="fig">Fig.Â 2C</xref>). Also, mutation of different viruses in the datasets existed in some particular written forms, such as nsp6-L3606fs and spike-glycoprotein-V6fs variants of SARS-CoV-2 (<xref rid="btac721-B28" ref-type="bibr">Zekri <italic toggle="yes">et al.</italic>, 2021</xref>). Furthermore, we analyzed false positive results of ViMRT, which was mainly caused by terms that are highly similar to the written form of virus mutation, such as human hepatoma cells (C3A) (<xref rid="btac721-B19" ref-type="bibr">Nishizawa <italic toggle="yes">et al.</italic>, 2016</xref>), where C3A was misidentified as a mutation.</p>
    <p>Several future directions can extend this work. Firstly, future study is warranted to expand the rules and regular expressions for more viruses with the emergence of special written forms. With the rapid growth of literature data, we will continue to expand our corpus of viruses, add more virus types and regularly update the literature of our search engine. Secondly, due to the particularity of writing styles of virus mutations, the current version of ViMRT mainly used the rule-based NLP method. In a preliminary study, we have explored whether it is possible to perform a binary classification task using machine learning models for discriminating sentences containing the mutation information to reduce the false positive. Both F1-scores of machine learning methods based on TF-IDF word embedding and TextCNN model could reach 0.8. In the future, with continuous updates and expansion of the virus data set constructed in this study, the state-of-the-art pre-trained language models, such as BERT (<xref rid="btac721-B10" ref-type="bibr">Devlin <italic toggle="yes">et al.</italic>, 2019</xref>), BioBERT (<xref rid="btac721-B15" ref-type="bibr">Lee <italic toggle="yes">et al.</italic>, 2020</xref>), PubMedBERT (<xref rid="btac721-B13" ref-type="bibr">Gu <italic toggle="yes">et al.</italic>, 2020</xref>), will be worth attempting. Thirdly, we will continue to extract and update more buried biological relationships associated with a viral function such as receptor binding and drug resistance.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported by the National Natural Science Foundation of China [81972914 to X.Y.Z. and 81573023 to X.Y.Z.]; the Fundamental Research Funds for the Central Universities [22120200014 to X.Y.Z.]; and Shanghai âRising Stars of Medical Talentâ Youth Development Program [2019-72 to Y.W.].</p>
    <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
  </sec>
</body>
<back>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>ViMRT software and the web are freely available at: <ext-link xlink:href="http://bmtongji.cn:1225/mutation/index" ext-link-type="uri">http://bmtongji.cn:1225/mutation/index</ext-link>.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btac721-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Allot</surname><given-names>A.</given-names></string-name></person-group><etal>et al</etal> (<year>2018</year>) <article-title>LitVar: a semantic search engine for linking genomic variant data in PubMed and PMC</article-title>. <source>Nucleic Acids Res</source>., <volume>46</volume>, <fpage>W530</fpage>â<lpage>W536</lpage>.<pub-id pub-id-type="pmid">29762787</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Araf</surname><given-names>Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2022</year>) <article-title>Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines</article-title>. <source>J. Med. Virol</source>., <volume>94</volume>, <fpage>1825</fpage>â<lpage>1832</lpage>.<pub-id pub-id-type="pmid">35023191</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Birgmeier</surname><given-names>J.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>AVADA: toward automated pathogenic variant evidence retrieval directly from the full-text literature</article-title>. <source>Genet. Med</source>., <volume>22</volume>, <fpage>362</fpage>â<lpage>370</lpage>.<pub-id pub-id-type="pmid">31467448</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Caporaso</surname><given-names>J.G.</given-names></string-name></person-group><etal>et al</etal> (<year>2007</year>) <article-title>MutationFinder: a high-performance system for extracting point mutation mentions from text</article-title>. <source>Bioinformatics</source>, <volume>23</volume>, <fpage>1862</fpage>â<lpage>1865</lpage>.<pub-id pub-id-type="pmid">17495998</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cejuela</surname><given-names>J.M.</given-names></string-name></person-group><etal>et al</etal> (<year>2017</year>) <article-title>nala: text mining natural language mutation mentions</article-title>. <source>Bioinformatics</source>, <volume>33</volume>, <fpage>1852</fpage>â<lpage>1858</lpage>.<pub-id pub-id-type="pmid">28200120</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>R.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>Hepatitis B virus mutation pattern rtA181S+T184I+M204I may contribute to multidrug resistance in clinical practice: analysis of a large cohort of Chinese patients</article-title>. <source>Antiviral Res</source>., <volume>180</volume>, <fpage>104852</fpage>.<pub-id pub-id-type="pmid">32569703</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>X.X.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>Occult HBV infection in patients with autoimmune hepatitis: a virological and clinical study</article-title>. <source>J. Microbiol. Immunol. Infect</source>., <volume>53</volume>, <fpage>946</fpage>â<lpage>954</lpage>.<pub-id pub-id-type="pmid">31153830</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davey</surname><given-names>N.E.</given-names></string-name></person-group><etal>et al</etal> (<year>2014</year>) <article-title>The HIV mutation browser: a resource for human immunodeficiency virus mutagenesis and polymorphism data</article-title>. <source>PLoS Comput. Biol</source>., <volume>10</volume>, <fpage>e1003951</fpage>.<pub-id pub-id-type="pmid">25474213</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>den Dunnen</surname><given-names>J.T.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>HGVS recommendations for the description of sequence variants: 2016 update</article-title>. <source>Hum. Mutat</source>., <volume>37</volume>, <fpage>564</fpage>â<lpage>569</lpage>.<pub-id pub-id-type="pmid">26931183</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B10">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Devlin</surname><given-names>J.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) BERT: pre-training of deep bidirectional transformers for language understanding. In: <italic toggle="yes">Proceedings of the 2019 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies</italic>, Vol. 1 (Long and Short Papers), Minneapolis, MN, USA. Association for Computational Linguistics. pp. 4171â4186. https://www.aclweb.org/anthology/N19-1423.</mixed-citation>
    </ref>
    <ref id="btac721-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Doughty</surname><given-names>E.</given-names></string-name></person-group><etal>et al</etal> (<year>2011</year>) <article-title>Toward an automatic method for extracting cancer- and other disease-related point mutations from the biomedical literature</article-title>. <source>Bioinformatics</source>, <volume>27</volume>, <fpage>408</fpage>â<lpage>415</lpage>.<pub-id pub-id-type="pmid">21138947</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Escandon</surname><given-names>K.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection</article-title>. <source>BMC Infect. Dis</source>., <volume>21</volume>, <fpage>710</fpage>.<pub-id pub-id-type="pmid">34315427</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B13">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Gu</surname><given-names>Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) Domain-specific language model pretraining for biomedical natural language processing.Â <italic toggle="yes">ACM Trans. Comput. Healthcare</italic>, <bold>3</bold>, 1â23. https://doi.org/10.1145/3458754.</mixed-citation>
    </ref>
    <ref id="btac721-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>B.X.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations</article-title>. <source>World J. Gastroenterol</source>., <volume>26</volume>, <fpage>5314</fpage>â<lpage>5327</lpage>.<pub-id pub-id-type="pmid">32994690</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>J.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>BioBERT: a pre-trained biomedical language representation model for biomedical text mining</article-title>. <source>Bioinformatics</source>, <volume>36</volume>, <fpage>1234</fpage>â<lpage>1240</lpage>.<pub-id pub-id-type="pmid">31501885</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>K.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>Recent advances of automated methods for searching and extracting genomic variant information from biomedical literature</article-title>. <source>Brief. Bioinform</source>., <volume>22</volume>, bbaa142.</mixed-citation>
    </ref>
    <ref id="btac721-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martin-Alonso</surname><given-names>S.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>Defective strand-displacement DNA synthesis due to accumulation of thymidine analogue resistance mutations in HIV-2 reverse transcriptase</article-title>. <source>ACS Infect. Dis</source>., <volume>6</volume>, <fpage>1140</fpage>â<lpage>1153</lpage>.<pub-id pub-id-type="pmid">32129987</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nishizawa</surname><given-names>T.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>Enhanced pregenomic RNA levels and lowered precore mRNA transcription efficiency in a genotype a hepatitis B virus genome with C1766T and T1768A mutations obtained from a fulminant hepatitis patient</article-title>. <source>J. Gen. Virol</source>., <volume>97</volume>, <fpage>2643</fpage>â<lpage>2656</lpage>.<pub-id pub-id-type="pmid">27473751</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sanjuan</surname><given-names>R.</given-names></string-name>, <string-name><surname>Domingo-Calap</surname><given-names>P.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Mechanisms of viral mutation</article-title>. <source>Cell. Mol. Life Sci</source>., <volume>73</volume>, <fpage>4433</fpage>â<lpage>4448</lpage>.<pub-id pub-id-type="pmid">27392606</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Soulie</surname><given-names>C.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy</article-title>. <source>J. Antimicrob. Chemother</source>., <volume>75</volume>, <fpage>1026</fpage>â<lpage>1030</lpage>.<pub-id pub-id-type="pmid">31976534</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2022</year>) <article-title>ViMIC: a database of human disease-related virus mutations, integration sites and cis-effects</article-title>. <source>Nucleic Acids Res</source>., <volume>50</volume>, <fpage>D918</fpage>â<lpage>D927</lpage>.<pub-id pub-id-type="pmid">34500462</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wei</surname><given-names>C.H.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>PubTator Central: automated concept annotation for biomedical full text articles</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>W587</fpage>â<lpage>W593</lpage>.<pub-id pub-id-type="pmid">31114887</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wei</surname><given-names>C.H.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>tmVar: a text mining approach for extracting sequence variants in biomedical literature</article-title>. <source>Bioinformatics</source>, <volume>29</volume>, <fpage>1433</fpage>â<lpage>1439</lpage>.<pub-id pub-id-type="pmid">23564842</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xie</surname><given-names>X.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera</article-title>. <source>Nat. Med</source>., <volume>27</volume>, <fpage>620</fpage>â<lpage>621</lpage>.<pub-id pub-id-type="pmid">33558724</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yeo</surname><given-names>J.Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>The determination of HIV-1 RT mutation rate, its possible allosteric effects, and its implications on drug resistance</article-title>. <source>Viruses</source>, <volume>12</volume>, <fpage>297</fpage>.<pub-id pub-id-type="pmid">32182845</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zapatka</surname><given-names>M.</given-names></string-name></person-group>, <etal>et al</etal>; <collab>PCAWG Consortium</collab>. (<year>2020</year>) <article-title>The landscape of viral associations in human cancers</article-title>. <source>Nat. Genet</source>., <volume>52</volume>, <fpage>320</fpage>â<lpage>330</lpage>.<pub-id pub-id-type="pmid">32025001</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zekri</surname><given-names>A.N.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes</article-title>. <source>Biochim. Biophys. Acta. Mol. Basis Dis</source>., <volume>1867</volume>, <fpage>166154</fpage>.<pub-id pub-id-type="pmid">33932525</pub-id></mixed-citation>
    </ref>
    <ref id="btac721-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>F.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>The functions of hepatitis B virus encoding proteins: viral persistence and liver pathogenesis</article-title>. <source>Front. Immunol</source>., <volume>12</volume>, <fpage>691766</fpage>.<pub-id pub-id-type="pmid">34456908</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
